Editorial
Editorial for “Validity and Reproducibility of ADNEX MR SCORING System in Diagnosis of Sonographically Indeterminate Adnexal Masses”
Isabelle Thomassin-Naggara MD, PhD,
Corresponding Author
Isabelle Thomassin-Naggara MD, PhD
Sorbonne Université, Paris, France
Department of Radiology, APHP – Hôpital Tenon, Paris, France
Author reprint requests to: I.T.-N., 4 rue de la Chine, 75020, Paris, France. E-mail: [email protected]
Search for more papers by this author Andrea Rockall MRCP, FRCR,
Andrea Rockall MRCP, FRCR
Imperial College of London, UK
Search for more papers by this author
Isabelle Thomassin-Naggara MD, PhD,
Corresponding Author
Isabelle Thomassin-Naggara MD, PhD
Sorbonne Université, Paris, France
Department of Radiology, APHP – Hôpital Tenon, Paris, France
Author reprint requests to: I.T.-N., 4 rue de la Chine, 75020, Paris, France. E-mail: [email protected]
Search for more papers by this author Andrea Rockall MRCP, FRCR,
Andrea Rockall MRCP, FRCR
Imperial College of London, UK
Search for more papers by this author
First published: 21 August 2020
No abstract is available for this article.
References
- 1Woo YL, Kyrgiou M, Bryant A, Everett T, Dickinson HO. Centralisation of services for gynaecological cancers — A Cochrane systematic review. Gynecol Oncol 2012; 126: 286-290.
- 2Froyman W, Landolfo C, Cock BD, et al. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): A 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 2019; 20: 448-458.
- 3Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial. Lancet 2016; 387: 945-956.
- 4Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: The prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011; 305: 2295-2303.
- 5Maturen KE, Blaty AD, Wasnik AP, et al. Risk stratification of adnexal cysts and cystic masses: Clinical performance of Society of Radiologists in ultrasound guidelines. Radiology 2017; 285: 650-659.
- 6Thomassin-Naggara I, Daraï E, Cuenod CA, Rouzier R, Callard P, Bazot M. Dynamic contrast-enhanced magnetic resonance imaging: A useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 2008; 28: 111-120.
- 7Thomassin-Naggara I, Aubert E, Rockall A, et al. Adnexal masses: Development and preliminary validation of an MR imaging scoring system. Radiology 2013; 267: 432-443.
- 8Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, et al. Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 2020; 3:e1919896.
- 9Basha MAA, Abdelrahman HM, Metwally MI, et al. Validity and reproducibility of the ADNEX MR scoring system in the diagnosis of sonographically indeterminate adnexal masses. J Magn Reson Imaging 2020; (this issue).
